Search by Drug Name or NDC
NDC 00173-0892-63 Nucala 100 mg/mL Details
Nucala 100 mg/mL
Nucala is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is MEPOLIZUMAB.
Product Information
NDC | 00173-0892 |
---|---|
Product ID | 0173-0892_6aaacdeb-43d4-4367-9d37-a9d6876344f1 |
Associated GPIs | 4460405500D530 4460405500E530 |
GCN Sequence Number | 079829 |
GCN Sequence Number Description | mepolizumab AUTO INJCT 100 MG/ML SUBCUT |
HIC3 | Z20 |
HIC3 Description | INTERLEUKIN-5 (IL-5) ANTAGONISTS, MAB |
GCN | 46414 |
HICL Sequence Number | 042775 |
HICL Sequence Number Description | MEPOLIZUMAB |
Brand/Generic | Brand |
Proprietary Name | Nucala |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | mepolizumab |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | SUBCUTANEOUS |
Active Ingredient Strength | 100 |
Active Ingredient Units | mg/mL |
Substance Name | MEPOLIZUMAB |
Labeler Name | GlaxoSmithKline LLC |
Pharmaceutical Class | Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA] |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA761122 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00173-0892-63 (00173089263)
NDC Package Code | 0173-0892-63 |
---|---|
Billing NDC | 00173089263 |
Package | 1 SYRINGE in 1 CARTON (0173-0892-63) / 1 mL in 1 SYRINGE |
Marketing Start Date | 2019-06-06 |
NDC Exclude Flag | N |
Pricing Information | N/A |